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Aims Fluctuations in left ventricular (LV) thresholds with cardiac resynchronization therapy (CRT) are unknown. The LV
capture management (LVCM) algorithm automatically measures LV thresholds on a daily basis and offers the oppor-
tunity to analyse threshold ﬂuctuations.
Methods
and results
A total of 282 patients implanted with a Medtronic Concerto
w CRT-D device were prospectively studied. Device
data were collected at periodic visits, including daily thresholds from the preceding 14 days and weekly threshold
ranges since implantation, acquired by the LVCM algorithm up to 12 months’ follow-up. Overall, LV thresholds
remained relatively stable, with 189/208 (91%) patients having a maximum increase in threshold of  1.0 V at any
time between their 1 and 6 month visits and 127/135 (94%) between the 6 and 12 month visits. However, increase
in threshold was signiﬁcantly affected by LV threshold amplitude. Of the 170 patients with a 1 month threshold of
 2.0 V, 159 (94%) had increases of ,1.0 V up to their 6 month visit, whereas 8/38 (21%) patients with .2.0 V
threshold had increases of .1.0 V (P ¼ 0.01). There were no signiﬁcant changes in LV threshold amplitude and ﬂuc-
tuation over the 12 month follow-up.
Conclusion For patients with low ( 2.0 V) LV thresholds, a safety margin of 1.0 V is sufﬁcient to ensure LV capture if phrenic
nerve stimulation is an issue, and may be even lower in devices with auto-adaptive capture management algorithms.
However, the margin should be greater in patients with higher thresholds because of larger ﬂuctuations. Left ventri-
cular capture management may be particularly useful in these patients to ensure LV capture without sacriﬁcing device
longevity.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
The prerequisite for successful cardiac resynchronization therapy
(CRT) is left ventricular (LV) capture. It has previously been
shown that up to 36% of patients had loss of CRT delivery at
some point in time over follow-up. One of the reasons for loss
of CRT delivery is loss of LV capture that may be observed in
10% of patients.
1 Left ventricular thresholds are known to be
higher than for right ventricular leads.
2–4 Left ventricular leads
implanted via coronary sinus tributaries may have less stable tip
contact than right ventricular endocardial leads, which results in
greater threshold ﬂuctuations. There is no consensus as to what
safety margin should be programmed for LV pacing. This
becomes an issue in cases of high thresholds (as pacing output
affects device longevity) as well as with phrenic nerve stimulation
(encountered in up to 18% of patients
5).
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Europace (2009) 11, 931–936
doi:10.1093/europace/eup105The advent of the Medtronic (Minneapolis, MN, USA) left ven-
tricular capture management (LVCM) algorithm that automatically
measures LV thresholds on a daily basis, offers us the opportunity
to analyse threshold ﬂuctuations. Our aims were to assess the
required safety margin for LV capture with CRT, and factors affect-
ing LV-threshold ﬂuctuations.
Methods
Patient population
A total of 282 patients enrolled in the Concerto
w AT Clinical Study
were included. The study was a prospective, multicentre, non-
randomized clinical trial designed to assess the safety and efﬁcacy of
the Concerto
w system. All patients had a standard indication for
CRT and an ICD (NYHA class III/IV under optimal medical therapy,
QRS 120 ms, LV ejection fraction  35%
6–8). Patient demographics
are shown in Table 1. All patients provided informed consent to the
study, which was approved by the institutional ethics committee.
Left ventricular capture management
(LVCM) algorithm
The Medtronic Concerto CRT-ICD features the LVCM algorithm,
which automatically measures LV thresholds as previously described
in detail.
9 Basically, capture detection is performed by pacing the LV
lead and assessing the timing of the ventricular sense on the right ven-
tricular lead. Since the interventricular interval tends to be shorter
than the atrioventricular (AV) interval, a captured test pace will be
sensed in the opposite chamber earlier than the AV conducted ventri-
cular sense on a non-captured test pace. After evaluating ventricular
rate (R–R variability ,200 ms and heart rate ,90 bpm), the algorithm
evaluates interventricular conduction (LVP–RVS interval of 60–
270 ms and variability of ,30 ms), and ascertains that atrioventricular
conduction is sufﬁciently longer than the interventricular time. An LV
capture detection window is initiated within 230 and þ20 ms of the
maximum LVP–RVS interval. Loss of capture is deﬁned as an RVS
event that occurs .50 ms after the maximal LVP–RVS interval (that
is assumed to be due to AV conduction). In patients without AV con-
duction or in patients with atrial ﬁbrillation (AF) with a well-controlled
ventricular rate, the interventricular conduction time may be used to
assess capture. Thresholds are measured at the programmed pulse-
width in 0.5 V steps between 0.5 and 3.5 V, and 1 V steps between
4.0 and 6.0 V (with three support cycles and one test cycle). After a
loss of capture is detected, amplitude is incremented until capture is
conﬁrmed on three consecutive tests. As thresholds are performed
in 0.5–1 V steps, it has to be borne in mind that a change in threshold
from one day to another is approximated to +0.4 V. Thus, a reported
increase in threshold of 0.5 V (e.g. measured as 1.0 and 1.5 V on sep-
arate days) could in reality mean changes of 0.1–0.9 V i.e. either from
1.0 to 1.1 V (D ¼ 0.1 V), or from 0.6 to 1.5 V (D ¼ 0.9 V). The LVCM
tests are scheduled on a daily basis at 01:00 am. If the test fails, a new
test is programmed after 30 min, for up to four times. The algorithm
has recently been shown to perform accurately, with 99.7% of in-ofﬁce
LVCM thresholds being within one step of the manual threshold.
9
Data collection and analysis
Patients were followed-up at 1, 3, 6, and 12 months (with a mean
follow-up of 10+3 months). Data were retrieved from save-to-disk
sessions. There were two LVCM datasets: daily LVCM thresholds
over the 14 days preceding device interrogation, and weekly threshold
maximum and minimum values over the last 80 weeks since
implantation. Examples of LVCM measurements in individual patients
are shown in Figure 1.
Maximum increase in left ventricular thresholds between
the 1 and 6 month visits
For the purposes of this analysis, the last measured LVCM threshold
from the 14 day dataset preceding the 1 month visit was recorded
as a surrogate for the in-ofﬁce manual threshold. The LVCM threshold
was chosen rather than the manual threshold, as deﬁnition of
threshold may have varied between study centres (i.e. loss of
capture vs. last captured beat). Maximum thresholds between 1 and
6 month visits were obtained from the weekly range data and com-
pared with the 1 month threshold to calculate the maximum increase
at any timepoint during this interval. The same was done between the
................................................................................
Table 1 Study population demographics (percentages
are rounded off)
Patient demographics (n 5 282)
Mean age (years) 66.9+11.5
Gender
Male 201 (71%)
Female 81 (29%)
Cardiomyopathy
Ischaemic 158 (56%)
Non-ischaemic 124 (44%)
NYHA class
III 261 (93%)
IV 21 (7%)
Hypertension 181 (64%)
Diabetes 105 (37%)
Atrial ﬁbrillation
Paroxysmal 81 (29%)
Persistent 15 (5%)
Permanent 0 (0%)
Indication
Primary prevention 243 (86%)
Secondary prevention 39 (14%)
Treatment
ACEI/ARB 244 (87%)
Beta-blocker 248 (88%)
Digitalis 108 (38%)
Diuretic 241 (85%)
Class III antiarrhythmic 67 (24%)
Implanted LV lead model
4194 168 (60%)
4193 88 (31%)
Other 26 (9%)
LV lead position
Lateral 97 (34%)
Postero-lateral 108 (38%)
Posterior 18 (6%)
Antero-lateral 32 (11%)
Anterior 5 (2%)
Other/missing data 22 (8%)
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with CRT are often followed-up every 6 months.
Day-to-day ﬂuctuations in left ventricular threshold over
two week periods
Analysis was restricted to complete 14 day datasets preceding device
interrogation (i.e. without any missing threshold measurements over
the last 14 days) that were obtained at any timepoint during the
12 month follow-up. Mean LV capture thresholds during the 2 week
periods were calculated for analysing effect on LV threshold
ﬂuctuation.
Statistical analysis
Day-to-day threshold ﬂuctuation over the 2 week periods was analysed
by the trimmed range (10th–90th percentiles i.e. the difference
between the one-but-largest and the one-but-smallest threshold
values). This analysis was chosen in preference of the more common
measures of dispersion: standard deviation (SD) and interquartile
range, to give additional weight to cases where two or more measure-
ments differ from the rest. Comparison of parameters between strata
(different timepoints in follow-up, lead model, and pacing conﬁguration)
was performed by an ANOVA-type test with GEE correction to take
into account multiple measurements per patient. Fisher’s exact test
was used for analysing categorical variables. The relationship between
trimmed range and LV threshold was evaluated by a linear regression
analysis with GEE correction. The relationship between increase in
threshold and 1 month threshold was analysed by ordinary least-squares
regression. Data are expressed as mean+SD. A two-sided P-value of
,0.05 was considered statistically signiﬁcant. All analyses were per-
formed using SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
Figure 1 Examples of LVCM data from device interrogations. (A) Patient with a low LV threshold (0.5 V at 0.4 ms) and low threshold ﬂuc-
tuation (0 V), seen with both the weekly range data (to the left of the solid vertical line), and over the last 14 days (right of the vertical line). (B)
Patient with a high LV threshold amplitude (mean threshold 4.6 V at 1 ms) and threshold ﬂuctuation (trimmed range of 1.5 V) calculated from
the 14 day data.
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Weekly threshold range data at any timepoint since implantation
were available in 262 patients. The remaining 20 (7%) patients
had absence of LVCM data. Of these, three patients were lost to
follow-up after hospital discharge, six patients had the LVCM algor-
ithm disabled, three patients had LV pacing disabled, another three
patients were programmed to a non-supporting mode (AAI in two
patients and DDIR in two patients), and in ﬁve (2%) patients the
LVCM algorithm was unable to measure a threshold. This was
likely due to similar LV–RV and AV conduction times in four
patients, and rapidly conducted persistent AF in one patient.
The LVCM algorithm was programmed to ‘adaptive’ 53% of the
time (meaning that the pacing amplitude was automatically adjusted
according to the LVCM threshold, with a pre-deﬁned safety
margin), and to ‘monitor’ 47% of the time (meaning that LVCM
threshold data were collected without adapting pacing output).
Maximum increase in left ventricular
threshold during the interval
between visits
One to 6 month interval
Weekly range data at the 6 month visit and 14 daily LVCM data at
1 month were available in 208 patients. As can be appreciated
from Figure 2, increase in threshold at any timepoint between 1
and 6 months was relatively low in the majority of patients,
with 171 (82%) patients showing increases of  0.5 V, and 189
(91%) increases of  1.0 V. Thus, 19 (9%) patients had increases
in LV threshold of .1.0 V, with values of up to 4 V (in 2
patients).
The probability of having a .1.0 V increase in threshold
during follow-up was signiﬁcantly affected by LV threshold at
1m o n t h( P ¼ 0.009), as was the mean increase in threshold
(P ¼ 0.002, Figure 3). Of the 170 patients with an LV threshold
of  2.0 V at 1 month, 159 (94%) never had an increase in
threshold of more than 1.0 V. For the other 38 patients with
an LV threshold of .2.0 V, 8 (21%) had increases in threshold
of .1.0 V (P ¼ 0.010).
Six to 12 month interval
Data at both 6 and 12 month visits were available in 135 patients.
Results were very similar to those obtained between the 1 and
6 month follow-ups. A total of 119 (88%) of patients had
a maximal threshold rise of  0.5 V at any timepoint between 6
and 12 months, and 127 (94%) with increases of  1.0 V. Thus,
eight (6%) patients had increases in LV threshold of .1.0 V, with
values of up to 5 V (in one patient). There was also a signiﬁcant
correlation between the 6 month threshold and the maximum
increase in threshold between 6 and 12 months (P ¼ 0.012).
Day-to-day left ventricular threshold
ﬂuctuation over 2 week periods
A total of 8176 daily LVCM measurements were analysed from 584
complete 14 day datasets in 207 patients. Of the 584 datasets, 546
(93%) had ﬂuctuations (measured by the trimmed range) of 0–
0.5 V, and 38 (7%) ﬂuctuations of  1.0 V. Of the 207 patients,
26 (13%) had one or more complete dataset with  1.0 V
threshold ﬂuctuation (and up to 3.0 V ﬂuctuation).
For comparison with the complete 14 daily measurements data-
sets, a total of 9327 weekly range measurements were analysed in
262 patients. Weekly ranges of 0 and 0.5 V were observed in 56
and 36% of weeks, respectively (totalling 92% of weeks together),
ranges of 1.0 V were observed in 5% of weeks, and of .1.0 V in
the remaining 3% of weeks. Thus, results were almost identical
with both analyses, indicating that outlier measurements of
LVCM (that may have affected the weekly range data) were not
an issue.
Figure 3 Maximum increase in LV threshold during the interval
between the 1 and 6 month visits plotted against the 1 month
threshold (n ¼ 208 patients). The histograms refer to the left
y-axis (percentage of patients in whom a .1.0 V threshold
increase was observed at some timepoint, P ¼ 0.009). The dots
and bars refer to the right y-axis (mean þ SD LV threshold
increase, P ¼ 0.002).
Figure 2 Maximum increase in LV threshold during the interval
between the 1 and 6 month visits, derived from weekly threshold
range data (n ¼ 208 patients).
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ventricular threshold ﬂuctuation
over the 2 week periods
Threshold amplitude
There was a signiﬁcant increase in daily LV threshold ﬂuctuation
with increase in mean LV threshold over the 2 week period. The
trimmed range increased by 0.27 V for each 1.0 V increase in
threshold (95% conﬁdence interval 0.19–0.35, P , 0.0001). As
the LVCM algorithm measures threshold in steps of 0.5 V for
thresholds up to 4.0 V and in steps of 1.0 V thereafter, we
explored a possible bias in increased threshold ﬂuctuation with
increased threshold amplitude by limiting the analysis to 563 data-
sets of 200 patients with LV threshold  4.0 V. The results
remained highly signiﬁcant (P , 0.0001 by linear regression).
Examples illustrating these ﬁndings are shown in Figure 1.
Time from implantation
There were no signiﬁcant differences in the 14 day threshold ﬂuc-
tuations or mean LV thresholds between the different follow-up
visits (Figure 4).
Lead models
There were no signiﬁcant differences in LV threshold or threshold
ﬂuctuation between the Medtronic Attain 4194 (n ¼ 126), the
Medtronic Attain 4193 (n ¼ 59), and other LV lead models (n ¼
22) (P ¼ 0.56).
Lead position
Due to the number of different categories with few observations,
we compared the postero-lateral position with all other lead pos-
itions, and found no difference in mean LV threshold (P ¼ 0.24) or
threshold ﬂuctuation (P ¼ 0.68).
Pacing conﬁguration
The ‘LV tip to RV coil’ conﬁguration (which is the nominal setting)
was programmed in 76% of the 2 week periods, the ‘LV tip to LV
ring’ conﬁguration of the bipolar 4194 lead was programmed in
21% of the periods and the ‘LV ring to RV coil’ (e.g. to avoid
phrenic nerve stimulation) programmed in 3% of the periods.
The vast majority (98% of patients) had no change of LV pacing
conﬁguration over follow-up. There were no differences in
threshold data between the ﬁrst two conﬁgurations. The ‘LV ring
to RV coil’ conﬁguration, however, showed signiﬁcantly higher
LV thresholds than with the other two conﬁgurations (2.53+
0.62 V vs. 1.44+0.85 V and 1.62+0.82 V, respectively, P ¼
0.001) and a trend towards higher threshold ﬂuctuations (0.44+
0.31 V vs. 0.28+0.38 V and 0.29+0.47 V, respectively, P ¼
0.11). It should be borne in mind that the 4194 lead has an LV
ring with a large surface (38 mm
2), and this feature may increase
thresholds when the ring is used as a cathode.
Pulse width
The majority (88% of patients) had the same pulse width pro-
grammed during the entire follow-up. A pulse width of 0.4 or
0.5 ms was programmed in 77% of complete datasets, and of
 0.6 ms in 23%. There were no differences in LV threshold ampli-
tude between these groups (1.44+0.73 V vs. 1.75+1.17 V, P ¼
0.22). Likewise, there were no differences in LV threshold ﬂuctu-
ation (0.27+0.37 V vs. 0.36+0.50 V, P ¼ 0.37).
Baseline characteristics
There was no signiﬁcant relation between LV threshold ﬂuctuation
and the following baseline characteristics: age (P ¼ 0.81), gender
(P ¼ 0.39), NYHA class (P ¼ 0.76), LVEF (P ¼ 0.42), QRS width
(P ¼ 0.57), heart failure aetiology (P ¼ 0.20), and the use of ACE
inhibitors (P ¼ 0.48) or beta-blockers (P ¼ 0.11).
Discussion
The main ﬁnding of our study is that the majority of patients have
stable LV thresholds over follow-up. Nevertheless, almost 1 in
10 patients has an increase of .1.0 V in LV threshold compared
with the 1 month threshold at some timepoint during the following
5 months. Our analysis indicates that high LV threshold ﬂuctuation
is signiﬁcantly related to higher LV pacing threshold amplitude. This
is most probably due to suboptimal stability and contact with the
epicardium of the LV electrode. Proximity to scar tissue may also
play a role, but the fact that patients with ischaemic and non-
ischaemic cardiomyopathy had similar threshold ﬂuctuation,
argues against this.
There are several clinical implications for devices without auto-
mated algorithms that adjust LV output according to threshold
measurements. First, in case of a high (.2.0 V) LV pacing
threshold, a sufﬁcient safety margin should be programmed to
ensure continuous LV capture. One in ﬁve of these patients has
a .1.0 V increase in LV thresholds during the 1–6 month
follow-up period. The conventional 100% safety margin (usually
obtained by doubling the threshold amplitude) should be sufﬁcient
in most cases. However, a high LV pacing output may lead to pre-
mature battery depletion or to other complications such as
Figure 4 Evolution of LV thresholds and threshold ﬂuctuation
after implantation. The number of patients with complete 14 day
LVCM datasets at each timepoint is shown (a total of 207 patients
were analysed).
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(set to the ‘adaptive’ mode) may be particularly useful in these
patients to ensure LV capture, without sacriﬁcing device longevity.
Second, in case of phrenic nerve stimulation, a low threshold safety
margin e.g. 1.0 V may be programmed, as long as the LV threshold
is low ( 2.0 V). The LVCM algorithm set to the ‘adaptive’ mode
may again be useful in these cases (and will also serve to maximize
device longevity). Analysis of day-to-day and weekly threshold ﬂuc-
tuation data in the device diagnostics is useful for determining the
optimal safety margin for a given patient (the default value being
1.5 V), and may allow margins as low as 0.5 V in patients with
stable day-to-day thresholds.
In the era of telemedicine, remote device follow-up is becoming
increasinglypopular.However,anin-ofﬁcevisitcanonlybereplaced
if the device is able to perform threshold checks automatically
(especially for the LV lead with CRT devices). A second aspect is
remote monitoring, with triggering of automatic alert messages in
caseofanLVthresholdrise.Withoutanalgorithmthatautomatically
adjusts pacing output (such as the ‘adaptive’ mode of LVCM), the
patient will require in-ofﬁce device reprogramming.
Study limitations
TheaccuracyoftheLVCMalgorithmwasnotveriﬁedmanuallyinour
study, and ﬂuctuations of LV thresholds may simply have been the
result of measurement error. However, the algorithm is already vali-
dated and has been shown to be extremely precise in a recent
report,
9 where errors were found only in 0.6% of tests (due to
PVCs falling into the capture detection window and as a result of
atrial loss of capture during the conduction checks). Furthermore,
by expressing threshold ﬂuctuations as the trimmed mean (10th–
90th percentile), the effect of outliers due to possible measurement
errorwouldhavebeenminimized.Thefactthattheanalysisusingthe
trimmed mean gave almost identical results compared with entire
weekly ranges indicates that outlier values were not an issue.
Automated LVCM measurements are performed at night, and
may therefore not reﬂect daytime thresholds. However, in the
study by Crossley et al.,
9 differences between the last night-time
LVCM measurement and the in-ofﬁce manual threshold was
within one voltage step in 96.4% of patients. Although this does
not rule out changes in threshold during exercise, it does
suggest that circadian variations and also to some extent changes
in threshold with posture are minor.
Our recommendations concerning programming of the LV
safety margin refer to the period between the 1 and 6 month
visits, and may not be applicable later on, or for longer follow-up
intervals. However, LV thresholds and threshold ﬂuctuations
remained constant up to 12 months, and it is unlikely that rec-
ommendations should differ after the 6 month visit.
Our results are derived from Medtronic leads (essentially the
4193 and 4194 models), and may not be applicable to other
leads with different characteristics and designs for stabilization.
Finally, as previously mentioned, the resolution of the LVCM
threshold measurements was limited by the 0.5–1 V threshold
steps. This may have led to overlap between categories of LV
threshold ﬂuctuations and also implies that the manually measured
threshold should ideally be rounded off to the upper 0.5 V before
adding the required safety margin to determine the pacing output.
Conclusions
While most patients with CRT show very little ﬂuctuation in LV
thresholds, there are individuals who show marked ﬂuctuations,
especially those patients with higher (.2.0 V) capture thresholds.
The LVCM algorithm is useful for automatically adjusting the
pacing output in case of threshold ﬂuctuation, especially in patients
with high LV thresholds (in order to avoid premature battery
depletion) and in those with phrenic nerve stimulation (where
low safety margins may be required). In devices without this
feature, a 1.0 V safety margin may be empirically set if the LV
threshold is low ( 2.0 V), but a greater margin (e.g. double the
threshold) may be necessary in case of high thresholds, due to
wider day-to-day ﬂuctuations.
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